We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
The Pediatric Forum |

Piracetam Study: Poorly Designed and Misinterpreted—Reply

Nancy J. Lobaugh, PhD; Gideon Koren, MD; Joanne Rovet, PhD; Robert Haslam, MD
Arch Pediatr Adolesc Med. 2001;155(10):1175-1176. doi:10.1001/archpedi.155.10.1175.
Text Size: A A A
Published online


In reply

Dr Black raised the issue of the direction of the differences in the grand averages between piracetam and the placebo, which ignores both the psychological importance and statistical significance of the differences. His misunderstanding may have arisen because we converted the results to z-score values so all could be displayed in a single figure. This facilitated comparisons across measures but obscured the precise magnitude of the differences. While the mean differences may have favored piracetam over the placebo in some cases, the confidence intervals clearly indicate that an outcome in favor of the placebo was also possible. As we pointed out in the article, the largest difference between the 2 conditions was 0.55 SD, and this was found on the first trial of verbal learning. For this measure, the difference of 0.55 SD reflects a mean (± SD) of 2.89 (± 0.39) words recalled while taking piracetam compared with 2.06 (± 0.31) words recalled while taking the placebo. Finding 46 grand averages of this magnitude or smaller is not sufficiently compelling to conclude that piracetam use yielded more positive effects.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.